1. Crowcroft NS, Stein C, Duclos P, Birmingham M. How best to estimate the global burden of pertussis? Lancet Infect Dis. 2003; 3:413–418. PMID:
12837346.
Article
2. Heymann DL. Control of communicable diseases manual. Washington, DC: American Public Health Association;2008.
3. Choe YJ, Park YJ, Jung C, Bae GR, Lee DH. National pertussis surveillance in South Korea 1955–2011: epidemiological and clinical trends. Int J Infect Dis. 2012; 16:e850–e854. PMID:
22921258.
Article
4. Roush SW, Murphy TV. Vaccine-Preventable Disease Table Working Group. Historical comparisons of morbidity and mortality for vaccine-preventable diseases in the United States. JAMA. 2007; 298:2155–2163. PMID:
18000199.
Article
5. Lee SY, Han SB, Kang JH, Kim JS. Pertussis prevalence in Korean adolescents and adults with persistent cough. J Korean Med Sci. 2015; 30:988–990. PMID:
26130965.
Article
6. Korea Centers for Disease Control and Prevention. 2013 Korea National Immunization Survey. Cheongju: Korea Centers for Disease Control and Prevention;2013.
7. Korea Centers for Disease Control and Prevention. Disease Web Statistics System [Internet]. Cheongju: Korea Centers for Disease Control and Prevention;2017. cited 2017 Nov 12. Available from:
http://is.cdc.go.kr.
8. Wendelboe AM, Van Rie A, Salmaso S, Englund JA. Duration of immunity against pertussis after natural infection or vaccination. Pediatr Infect Dis J. 2005; 24(5 Suppl):S58–S61. PMID:
15876927.
Article
9. Khetsuriani N, Bisgard K, Prevots DR, et al. Pertussis outbreak in an elementary school with high vaccination coverage. Pediatr Infect Dis J. 2001; 20:1108–1112. PMID:
11740314.
Article
10. Korea Centers for Disease Control and Prevention. Case definition for national notifiable infectious disease. Cheongju: Korea Centers for Disease Control and Prevention;2017.
11. Korea Centers for Disease Control and Prevention. Guideline for the laboratory diagnosis for national notifiable infectious disease. Cheongju: Korea Centers for Disease Control and Prevention;2016.
12. He Q, Viljanen MK, Olander RM, et al. Antibodies to filamentous hemagglutinin of Bordetella pertussis and protection against whooping cough in schoolchildren. J Infect Dis. 1994; 170:705–708. PMID:
8077734.
Article
13. Brennan M, Strebel P, George H, et al. Evidence for transmission of pertussis in schools, Massachusetts, 1996: epidemiologic data supported by pulsed-field gel electrophoresis studies. J Infect Dis. 2000; 181:210–215. PMID:
10608769.
Article
14. Wang K, Fry NK, Campbell H, et al. Whooping cough in school age children presenting with persistent cough in UK primary care after introduction of the preschool pertussis booster vaccination: prospective cohort study. BMJ. 2014; 348:g3668. PMID:
24961836.
Article
15. McNamara LA, Skoff T, Faulkner A, et al. Reduced severity of pertussis in persons with age-appropriate pertussis vaccination-United States, 2010–2012. Clin Infect Dis. 2017; 65:811–818. PMID:
29017283.
Article
16. Alamaw SD, Kassa AW, Gelaw YA. Pertussis outbreak investigation of Mekdela district, South Wollo zone, Amhara region, North-West Ethiopia. BMC Res Notes. 2017; 10:420. PMID:
28830538.
Article
17. Pawloski LC, Queenan AM, Cassiday PK, et al. Prevalence and molecular characterization of pertactin-deficient Bordetella pertussis in the United States. Clin Vaccine Immunol. 2014; 21:119–125. PMID:
24256623.
Article
18. Centers for Disease Control and Prevention (CDC). Schoolassociated pertussis outbreak: Yavapai County, Arizona, September 2002–February 2003. MMWR Morb Mortal Wkly Rep. 2004; 53:216–219. PMID:
15029116.
19. Mooi FR, Van Der, De Melker HE. Pertussis resurgence: waning immunity and pathogen adaptation: two sides of the same coin. Epidemiol Infect. 2014; 142:685–694. PMID:
23406868.